151 related articles for article (PubMed ID: 25913566)
1. Reply to the comment by Cipolla et al. on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
Weers J
Adv Drug Deliv Rev; 2015 May; 85():e8-e10. PubMed ID: 25913566
[No Abstract] [Full Text] [Related]
2. Reply to the comment by de Boer and Hoppentocht on: inhaled antimicrobial therapy - barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
Weers J
Adv Drug Deliv Rev; 2015 May; 85():e3-5. PubMed ID: 25913567
[No Abstract] [Full Text] [Related]
3. Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
Cipolla D; Froehlich J; Gonda I
Adv Drug Deliv Rev; 2015 May; 85():e6-7. PubMed ID: 25913564
[No Abstract] [Full Text] [Related]
4. Comment on: inhaled antimicrobial therapy-Barriers to effective treatment, by J.Weers, Adv. Drug Deliv. Rev. (2014), http://dx.doi.org/ 10.1016/j.addr.2014.08.013.
de Boer AH; Hoppentocht M
Adv Drug Deliv Rev; 2015 May; 85():e1-2. PubMed ID: 25913565
[No Abstract] [Full Text] [Related]
5. Inhaled antimicrobial therapy - barriers to effective treatment.
Weers J
Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary drug delivery systems for antimicrobial agents: facts and myths.
Falagas ME; Michalopoulos A; Metaxas EI
Int J Antimicrob Agents; 2010 Feb; 35(2):101-6. PubMed ID: 19939637
[TBL] [Abstract][Full Text] [Related]
7. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J
Adv Drug Deliv Rev; 2015 May; 85():65-82. PubMed ID: 25446140
[TBL] [Abstract][Full Text] [Related]
8. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance--fluoroquinolones and the tiger's tail.
Tillotson GS; Carroll J; Klugman KP
J Chemother; 2006 Jun; 18(3):328-30. PubMed ID: 17129847
[No Abstract] [Full Text] [Related]
10. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
Pell DM
Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
[No Abstract] [Full Text] [Related]
11. Inhaled Antibiotics for Ventilator-Associated Infections.
Palmer LB
Infect Dis Clin North Am; 2017 Sep; 31(3):577-591. PubMed ID: 28779834
[TBL] [Abstract][Full Text] [Related]
12. Delivery of antibiotics to the respiratory tract: an update.
Traini D; Young PM
Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for antimicrobial therapy of acute upper respiratory tract infections in Taiwan.
J Microbiol Immunol Infect; 2002 Dec; 35(4):272-3. PubMed ID: 12542257
[No Abstract] [Full Text] [Related]
14. Drugs for bacterial infections.
Treat Guidel Med Lett; 2010 Jun; 8(94):43-52. PubMed ID: 20489679
[No Abstract] [Full Text] [Related]
15. Antimicrobial drugs in the treatment of respiratory infections.
Sen P
J Indian Med Assoc; 1979 Jul; 73(1):18-20. PubMed ID: 536598
[No Abstract] [Full Text] [Related]
16. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
Carter PL
Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
[TBL] [Abstract][Full Text] [Related]
17. Inhaled antibiotics for gram-negative respiratory infections.
Hudson R; Olson Blair B
Future Med Chem; 2011 Oct; 3(13):1663-77. PubMed ID: 21942255
[TBL] [Abstract][Full Text] [Related]
18. Respiratory infections and antimicrobial therapy.
Saunders WH
Otolaryngol Clin North Am; 1970 Jun; 3(2):303-17. PubMed ID: 5006503
[No Abstract] [Full Text] [Related]
19. Combating antimicrobial resistance: quality standards for prescribing for respiratory infections in Vietnam.
Li R; van Doorn HR; Wertheim HFL; Khue LN; Ha NTB; Dat VQ; Hanh CT; Nga DTT; Trang NNM; Nadjm B; Cluzeau F; Kinh NV; Trung NV; Huong NTL; Chau NQ; Huong Q; Thao LT; Hong LTA; Oanh TTM; Islam J; Roberts CM; Chalkidou K
Lancet Glob Health; 2016 Nov; 4(11):e789. PubMed ID: 27765287
[No Abstract] [Full Text] [Related]
20. Bacteria in the respiratory tract-how to treat? Or do not treat?
Prat C; Lacoma A
Int J Infect Dis; 2016 Oct; 51():113-122. PubMed ID: 27776777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
